Clinical Trials Browser

Withdrawn × Adenocarcinoma × Gemcitabine × Clear all

NCT01045941 2016-10-06

Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma

Phase 2 Withdrawn

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT01830322 2013-08-14

Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer

Phase 2 Withdrawn

Adenocarcinoma, Neoplasm Metastasis, Neoplasms